Indeed, EBV-specific T cells from SLE patients exhibit a reduced capacity to secrete IFN-γ, TNF-α, IL-2 and MIP-1β and an impaired cytotoxic granule exocytosis process. The gene discussed is IL2; the disease is systemic lupus erythematosus.